Sustainable R&D Framework Needed to Address Essential Health Needs of Developing Countries

[Geneva, Switzerland – 21 May 2012]
DNDi Welcomes World Health Organization Expert Recommendations to Begin Negotiations for an R&D Convention at the World Health Assembly
After a decade-long process of analysis and deliberations on ways to better address the health needs of developing countries, a recently released report of the Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG) will be discussed this week at the 65th World Health Assembly (agenda item 13.14). The Drugs for Neglected Diseases initiative (DNDi), a not-for-profit research and development (R&D) organization, welcomes the experts’ conclusion that ‘the time has now come for WHO Member States to begin a process leading to the negotiation of a binding agreement on R&D relevant to the health needs of developing countries’.
[Português] [Español]

Forum 2012: COHRED / Global Forum for Health Research

[April 24-26, 2012]
Cape Town, South Africa
The Council on Health Research and Development Group (The COHRED Group) in collaboration with partners and Governments, launched a new series of Global Forum for Health Research meetings on the theme: ‘Beyond aid…research and innovation as key drivers of health, equity and development’.

Private and Public Partners Unite to Combat 10 Neglected Tropical Diseases by 2020

[London – 30 January 2012]
Partners pledge innovative, coordinated action aimed at new World Health Organisation goals
Today, 13 pharmaceutical companies, the U.S., U.K. and U.A.E governments, the Bill & Melinda Gates Foundation, the World Bank and other global health organisations announced a new, coordinated push to accelerate progress toward eliminating or controlling 10 neglected tropical diseases (NTDs) by the end of the decade.

Filling R&D Gaps Key to Succeeding in NTD Control and Elimination Goals by 2020

[Geneva, Switzerland – 30 January 2012]
On the occasion of today’s high-level event in London, ‘Uniting to Combat Neglected Tropical Diseases,’ organized in support of the new World Health Organization (WHO) Neglected Tropical Disease (NTD) 2020 Roadmap, the Drugs for Neglected Diseases initiative (DNDi) welcomes the commitments from various partners and emphasizes that filling the major gaps in research and development (R&D) to develop new treatment and diagnostic tools is key to effectively support elimination or control of targeted NTDs by 2020. [Deutsch] [Español] [Português] [Japanese]

Preencher as Lacunas em P&D é a Chave para Controlar e Eliminar as Doenças Tropicais Negligenciadas

[Geneva, Switzerland – 30 January 2012]
Devido ao evento de alto nível “Unidos para Combater às Doenças Tropicais Negligenciadas”, realizado hoje, em Londres, em apoio ao novo “Roteiro 2020 para as Doenças Tropicais Negligenciadas” da Organização Mundial da Saúde (OMS), a iniciativa Medicamentos para Doenças Negligenciadas (DNDi) dá as boas-vindas aos compromissos de vários parceiros e enfatiza a necessidade de preencher as lacunas em pesquisa e desenvolvimento (P & D) para que se possa desenvolver novos tratamentos e ferramentas de diagnóstico para apoiar de forma eficaz a controlar ou eliminar determinadas doenças negligenciadas até 2020.
[English] [Deutsch] [Español] [Japanese]

Llenar las lagunas en investigación y desarrollo es la clave para controlar y eliminar las enfermedades tropicales olvidadas

[Geneva, Switzerland – 30 January 2012]
Con motivo del evento de alto nivel “Unidos para combatir las enfermedades tropicales olvidadas” organizado en apoyo de la nueva «Hoja de Ruta 2020 para las enfermedades tropicales olvidadas» de la Organización Mundial de la Salud (OMS), la iniciativa Medicamentos para enfermedades Olvidadas (DNDi, por sus siglas en inglés) dio la bienvenida a los nuevos compromisos de varios socios y enfatizó la necesidad de llenar las lagunas en investigación y desarrollo para poder desarrollar nuevas herramientas de diagnóstico y nuevos tratamientos que permitan controlar o eliminar determinadas enfermedades olvidadas para 2020.
[English]
[Deutsch] [Português] [Japanese]

Forschungslücken müssen geschlossen werden, wenn vernachlässigte Tropenkrankheiten bis 2020 bekämpft und eliminiert sein sollen

[Geneva, Switzerland – 30 January 2012]
Anlässlich der Konferenz zum Thema „Uniting to Combat Neglected Tropical Diseases“ in London begrüßt DNDi das verstärkte Engagement im Kampf gegen vernachlässigte Tropenkrankheiten. Darüber hinaus verkündet die not-for-profit-Organisation Vereinbarungen mit mehreren Pharmaunternehmen, darunter auch Bayer Healthcare.
[English] [Español] [Português] [Japanese]

New recommendations to enhance registration processes of drugs for neglected diseases in Africa

[Geneva, Switzerland/ Pretoria, South Africa – February 19, 2010]
A report commissioned by DNDi assesses pathway to facilitate review of new neglected diseases’ drugs by African experts 
Today, at the ‘Council on Health Research for Development’ (COHRED)  and ‘The New Partnership for Africa’s Development’ (NEPAD) meeting in Pretoria, South Africa, the Drugs for Neglected Diseases initiative (DNDi) and the George Institute for International Health release the report “Registering New Drugs: the African Context”. The report issues new recommendations to strengthen regulatory authorisation processes in Africa for drugs against neglected diseases.

Cohred & Nepad Meeting: Strengthening Pharmaceutical Innovation in Africa

[February 18-20, 2010]
Pretoria, South Africa
The meeting addressed the problems and challenges faced by African countries in their quest to increase access to medicines and research for innovative products, and to stimulate production of medicines in Africa. DNDi presented the background need for strengthened regulatory capacity in Africa in the Plenary session, and also held a Regulatory workshop. DNDi and the George Institute took advantage  of this meeting to launch their joint report: “Registering New Drugs: The African context”.

DNDi‘s Regulatory Workshop

[June 24, 2009]
Nairobi, Kenya
How to Strengthen Capacity in Africa for the Registration of New Drugs for Neglected Diseases? That was the topic discussed by more than 50 attendees at the workshop which was held during DNDi‘s 2nd Stakeholders’ and 3rd African Meetings, in Nairobi, Kenya.